Skip to main content
Premium Trial:

Request an Annual Quote

Memorial Sloan Kettering, Seres Partner to Develop Microbiome Cancer Drugs

NEW YORK (GenomeWeb) – Seres Therapeutics announced today that it has formed a multi-year strategic alliance with Memorial Sloan Kettering Cancer Center (MSKCC) to discover and develop microbiome drugs that improve cancer therapies.

Specifically, the partners will use bacteria from the human microbiome to prevent transplant-related infections and graft-versus-host disease in patients undergoing hematopoietic stem cell transplantation (HSCT)-based cancer treatment. They also hope to increase the safety and efficacy of checkpoint inhibitor-based cancer immunotherapeutics.

MSKCC "scientists have been at the forefront of research into the crucial role of the microbiome in disease, and we believe our combined insights and capabilities could be strongly synergistic and pave the way toward clinically meaningful therapeutic applications for patients with various cancers and serious conditions related to their treatment," Seres Chairman and CEO Roger Pomerantz said in a statement.

Under the terms of the deal, the partners will use patient samples from MSKCC clinical studies to generate microbiome metagenomic signatures and other clinical data that could help in designing of novel microbiome therapeutics.

Seres will receive a global license to MSKCC intellectual property on the use of bacterial compositions in treating HSCT patients and related areas. Seres is currently developing SER-155, a preclinical therapeutic composed of in vitro cultured bacterial species for improving HSCT patient outcomes.

Additional terms of the arrangement were not disclosed.

The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.